ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lab-synthesized Heparin Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-17S17507
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Lab synthesized Heparin Market Research Report 2024
BUY CHAPTERS

Global Lab-synthesized Heparin Market Research Report 2024

Code: QYRE-Auto-17S17507
Report
May 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Organization
Rensselaer Polytechnic Institute
Fresenius Kabi
Amphastar
LEO Pharma
Sanofi
Pfizer Inc
Shenzhen Hepalink
Changzhou Qianhong Biopharma
Yantai Dongcheng Biochemicals Co., Ltd
Techdow USA
Bruan

Lab-synthesized Heparin Market Size

The global Lab-synthesized Heparin market was valued at US$ 7820 million in 2023 and is anticipated to reach US$ 9755 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Lab-synthesized Heparin Market

Lab-synthesized Heparin Market

Heparin, the world's most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine. Intravenous or subcutaneous organization of anticoagulant low molecular weight heparin (LMWH) is conceivable. For example, enoxaparin and dalteparin capability by first enacting antithrombin III, which then, at that point, deactivates thrombin and component Xa to accomplish its impact.
The British National Formulary (BNF) has approved Low Molecular Weight Heparin (LMWH). The National Institute for Health and Care Excellence (NICE) has stated that LMWHs can be used to treat venous thromboembolism in pregnancy, DVT, and pulmonary embolism (PE) in non-pregnant women, as well as prophylactic treatment for deep vein thrombosis (DVT) in patients in medium- and high-risk categories (medical, orthopedic, and surgical patients). Due to the widespread usage of LMWH around the world, the LMWH market sector is anticipated to comprise a sizable portion of the research market, which is driving the market CAGR. According to the CDC, around 60,000-100,000 Americans pass on from this condition consistently. In addition, low molecular weight heparin has a longer shelf-life, reduces and eliminates medical clinic stays, and can be self-controlled at home through subcutaneous infusion, which favors its mass adoption.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lab-synthesized Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lab-synthesized Heparin.
The Lab-synthesized Heparin market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Lab-synthesized Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lab-synthesized Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lab-synthesized Heparin Market Report

Report Metric Details
Report Name Lab-synthesized Heparin Market
Accounted market size in 2023 US$ 7820 million
Forecasted market size in 2030 US$ 9755 million
CAGR 3.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Low Molecular Weight Heparin
  • Unfractionated Heparin
Segment by Application
  • Venous Thromboembolism
  • Atrial Fibrillation/Flutter
  • Coronary Artery Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fresenius Kabi, Techdow USA, Bruan, Amphastar, Leo Pharma, Sanofi, Pfizer, Shenzhen Hepalink, Changzhou Qianhong Biopharma, Yantai Dongcheng Biochemicals Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lab-synthesized Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lab-synthesized Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Lab-synthesized Heparin Market growing?

Ans: The Lab-synthesized Heparin Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Lab-synthesized Heparin Market size in 2030?

Ans: The Lab-synthesized Heparin Market size in 2030 will be US$ 9755 million.

Who are the main players in the Lab-synthesized Heparin Market report?

Ans: The main players in the Lab-synthesized Heparin Market are Fresenius Kabi, Techdow USA, Bruan, Amphastar, Leo Pharma, Sanofi, Pfizer, Shenzhen Hepalink, Changzhou Qianhong Biopharma, Yantai Dongcheng Biochemicals Co., Ltd

What are the Application segmentation covered in the Lab-synthesized Heparin Market report?

Ans: The Applications covered in the Lab-synthesized Heparin Market report are Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease, Others

What are the Type segmentation covered in the Lab-synthesized Heparin Market report?

Ans: The Types covered in the Lab-synthesized Heparin Market report are Low Molecular Weight Heparin, Unfractionated Heparin

1 Lab-synthesized Heparin Market Overview
1.1 Product Definition
1.2 Lab-synthesized Heparin by Type
1.2.1 Global Lab-synthesized Heparin Market Value Comparison by Type (2024-2030)
1.2.2 Low Molecular Weight Heparin
1.2.3 Unfractionated Heparin
1.3 Lab-synthesized Heparin by Application
1.3.1 Global Lab-synthesized Heparin Market Value by Application (2024-2030)
1.3.2 Venous Thromboembolism
1.3.3 Atrial Fibrillation/Flutter
1.3.4 Coronary Artery Disease
1.3.5 Others
1.4 Global Lab-synthesized Heparin Market Size Estimates and Forecasts
1.4.1 Global Lab-synthesized Heparin Revenue 2019-2030
1.4.2 Global Lab-synthesized Heparin Sales 2019-2030
1.4.3 Global Lab-synthesized Heparin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lab-synthesized Heparin Market Competition by Manufacturers
2.1 Global Lab-synthesized Heparin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lab-synthesized Heparin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lab-synthesized Heparin Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Lab-synthesized Heparin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lab-synthesized Heparin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lab-synthesized Heparin, Product Type & Application
2.7 Global Key Manufacturers of Lab-synthesized Heparin, Date of Enter into This Industry
2.8 Global Lab-synthesized Heparin Market Competitive Situation and Trends
2.8.1 Global Lab-synthesized Heparin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lab-synthesized Heparin Players Market Share by Revenue
2.8.3 Global Lab-synthesized Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lab-synthesized Heparin Market Scenario by Region
3.1 Global Lab-synthesized Heparin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lab-synthesized Heparin Sales by Region: 2019-2030
3.2.1 Global Lab-synthesized Heparin Sales by Region: 2019-2024
3.2.2 Global Lab-synthesized Heparin Sales by Region: 2025-2030
3.3 Global Lab-synthesized Heparin Revenue by Region: 2019-2030
3.3.1 Global Lab-synthesized Heparin Revenue by Region: 2019-2024
3.3.2 Global Lab-synthesized Heparin Revenue by Region: 2025-2030
3.4 North America Lab-synthesized Heparin Market Facts & Figures by Country
3.4.1 North America Lab-synthesized Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lab-synthesized Heparin Sales by Country (2019-2030)
3.4.3 North America Lab-synthesized Heparin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lab-synthesized Heparin Market Facts & Figures by Country
3.5.1 Europe Lab-synthesized Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lab-synthesized Heparin Sales by Country (2019-2030)
3.5.3 Europe Lab-synthesized Heparin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lab-synthesized Heparin Market Facts & Figures by Region
3.6.1 Asia Pacific Lab-synthesized Heparin Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lab-synthesized Heparin Sales by Region (2019-2030)
3.6.3 Asia Pacific Lab-synthesized Heparin Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lab-synthesized Heparin Market Facts & Figures by Country
3.7.1 Latin America Lab-synthesized Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lab-synthesized Heparin Sales by Country (2019-2030)
3.7.3 Latin America Lab-synthesized Heparin Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lab-synthesized Heparin Market Facts & Figures by Country
3.8.1 Middle East and Africa Lab-synthesized Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lab-synthesized Heparin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lab-synthesized Heparin Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lab-synthesized Heparin Sales by Type (2019-2030)
4.1.1 Global Lab-synthesized Heparin Sales by Type (2019-2024)
4.1.2 Global Lab-synthesized Heparin Sales by Type (2025-2030)
4.1.3 Global Lab-synthesized Heparin Sales Market Share by Type (2019-2030)
4.2 Global Lab-synthesized Heparin Revenue by Type (2019-2030)
4.2.1 Global Lab-synthesized Heparin Revenue by Type (2019-2024)
4.2.2 Global Lab-synthesized Heparin Revenue by Type (2025-2030)
4.2.3 Global Lab-synthesized Heparin Revenue Market Share by Type (2019-2030)
4.3 Global Lab-synthesized Heparin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lab-synthesized Heparin Sales by Application (2019-2030)
5.1.1 Global Lab-synthesized Heparin Sales by Application (2019-2024)
5.1.2 Global Lab-synthesized Heparin Sales by Application (2025-2030)
5.1.3 Global Lab-synthesized Heparin Sales Market Share by Application (2019-2030)
5.2 Global Lab-synthesized Heparin Revenue by Application (2019-2030)
5.2.1 Global Lab-synthesized Heparin Revenue by Application (2019-2024)
5.2.2 Global Lab-synthesized Heparin Revenue by Application (2025-2030)
5.2.3 Global Lab-synthesized Heparin Revenue Market Share by Application (2019-2030)
5.3 Global Lab-synthesized Heparin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Company Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Fresenius Kabi Lab-synthesized Heparin Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Techdow USA
6.2.1 Techdow USA Company Information
6.2.2 Techdow USA Description and Business Overview
6.2.3 Techdow USA Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Techdow USA Lab-synthesized Heparin Product Portfolio
6.2.5 Techdow USA Recent Developments/Updates
6.3 Bruan
6.3.1 Bruan Company Information
6.3.2 Bruan Description and Business Overview
6.3.3 Bruan Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bruan Lab-synthesized Heparin Product Portfolio
6.3.5 Bruan Recent Developments/Updates
6.4 Amphastar
6.4.1 Amphastar Company Information
6.4.2 Amphastar Description and Business Overview
6.4.3 Amphastar Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amphastar Lab-synthesized Heparin Product Portfolio
6.4.5 Amphastar Recent Developments/Updates
6.5 Leo Pharma
6.5.1 Leo Pharma Company Information
6.5.2 Leo Pharma Description and Business Overview
6.5.3 Leo Pharma Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leo Pharma Lab-synthesized Heparin Product Portfolio
6.5.5 Leo Pharma Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Lab-synthesized Heparin Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pfizer Lab-synthesized Heparin Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Shenzhen Hepalink
6.8.1 Shenzhen Hepalink Company Information
6.8.2 Shenzhen Hepalink Description and Business Overview
6.8.3 Shenzhen Hepalink Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shenzhen Hepalink Lab-synthesized Heparin Product Portfolio
6.8.5 Shenzhen Hepalink Recent Developments/Updates
6.9 Changzhou Qianhong Biopharma
6.9.1 Changzhou Qianhong Biopharma Company Information
6.9.2 Changzhou Qianhong Biopharma Description and Business Overview
6.9.3 Changzhou Qianhong Biopharma Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Changzhou Qianhong Biopharma Lab-synthesized Heparin Product Portfolio
6.9.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.10 Yantai Dongcheng Biochemicals Co., Ltd
6.10.1 Yantai Dongcheng Biochemicals Co., Ltd Company Information
6.10.2 Yantai Dongcheng Biochemicals Co., Ltd Description and Business Overview
6.10.3 Yantai Dongcheng Biochemicals Co., Ltd Lab-synthesized Heparin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yantai Dongcheng Biochemicals Co., Ltd Lab-synthesized Heparin Product Portfolio
6.10.5 Yantai Dongcheng Biochemicals Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lab-synthesized Heparin Industry Chain Analysis
7.2 Lab-synthesized Heparin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lab-synthesized Heparin Production Mode & Process
7.4 Lab-synthesized Heparin Sales and Marketing
7.4.1 Lab-synthesized Heparin Sales Channels
7.4.2 Lab-synthesized Heparin Distributors
7.5 Lab-synthesized Heparin Customers
8 Lab-synthesized Heparin Market Dynamics
8.1 Lab-synthesized Heparin Industry Trends
8.2 Lab-synthesized Heparin Market Drivers
8.3 Lab-synthesized Heparin Market Challenges
8.4 Lab-synthesized Heparin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Organization
Rensselaer Polytechnic Institute
Fresenius Kabi
Amphastar
LEO Pharma
Sanofi
Pfizer Inc
Shenzhen Hepalink
Changzhou Qianhong Biopharma
Yantai Dongcheng Biochemicals Co., Ltd
Techdow USA
Bruan
List of Tables
 Table 1. Global Lab-synthesized Heparin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Lab-synthesized Heparin Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Lab-synthesized Heparin Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Lab-synthesized Heparin Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Lab-synthesized Heparin Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Lab-synthesized Heparin Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Lab-synthesized Heparin Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Lab-synthesized Heparin Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Lab-synthesized Heparin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lab-synthesized Heparin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lab-synthesized Heparin, Product Type & Application
 Table 12. Global Key Manufacturers of Lab-synthesized Heparin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lab-synthesized Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lab-synthesized Heparin as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lab-synthesized Heparin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Lab-synthesized Heparin Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Lab-synthesized Heparin Sales Market Share by Region (2019-2024)
 Table 19. Global Lab-synthesized Heparin Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Lab-synthesized Heparin Sales Market Share by Region (2025-2030)
 Table 21. Global Lab-synthesized Heparin Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Lab-synthesized Heparin Revenue Market Share by Region (2019-2024)
 Table 23. Global Lab-synthesized Heparin Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Lab-synthesized Heparin Revenue Market Share by Region (2025-2030)
 Table 25. North America Lab-synthesized Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Lab-synthesized Heparin Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Lab-synthesized Heparin Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Lab-synthesized Heparin Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Lab-synthesized Heparin Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Lab-synthesized Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Lab-synthesized Heparin Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Lab-synthesized Heparin Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Lab-synthesized Heparin Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Lab-synthesized Heparin Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Lab-synthesized Heparin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Lab-synthesized Heparin Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Lab-synthesized Heparin Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Lab-synthesized Heparin Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Lab-synthesized Heparin Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Lab-synthesized Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Lab-synthesized Heparin Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Lab-synthesized Heparin Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Lab-synthesized Heparin Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Lab-synthesized Heparin Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Lab-synthesized Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Lab-synthesized Heparin Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Lab-synthesized Heparin Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Lab-synthesized Heparin Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Lab-synthesized Heparin Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Lab-synthesized Heparin Sales (K Dose) by Type (2019-2024)
 Table 51. Global Lab-synthesized Heparin Sales (K Dose) by Type (2025-2030)
 Table 52. Global Lab-synthesized Heparin Sales Market Share by Type (2019-2024)
 Table 53. Global Lab-synthesized Heparin Sales Market Share by Type (2025-2030)
 Table 54. Global Lab-synthesized Heparin Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Lab-synthesized Heparin Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Lab-synthesized Heparin Revenue Market Share by Type (2019-2024)
 Table 57. Global Lab-synthesized Heparin Revenue Market Share by Type (2025-2030)
 Table 58. Global Lab-synthesized Heparin Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Lab-synthesized Heparin Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Lab-synthesized Heparin Sales (K Dose) by Application (2019-2024)
 Table 61. Global Lab-synthesized Heparin Sales (K Dose) by Application (2025-2030)
 Table 62. Global Lab-synthesized Heparin Sales Market Share by Application (2019-2024)
 Table 63. Global Lab-synthesized Heparin Sales Market Share by Application (2025-2030)
 Table 64. Global Lab-synthesized Heparin Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Lab-synthesized Heparin Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Lab-synthesized Heparin Revenue Market Share by Application (2019-2024)
 Table 67. Global Lab-synthesized Heparin Revenue Market Share by Application (2025-2030)
 Table 68. Global Lab-synthesized Heparin Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Lab-synthesized Heparin Price (US$/Dose) by Application (2025-2030)
 Table 70. Fresenius Kabi Company Information
 Table 71. Fresenius Kabi Description and Business Overview
 Table 72. Fresenius Kabi Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Fresenius Kabi Lab-synthesized Heparin Product
 Table 74. Fresenius Kabi Recent Developments/Updates
 Table 75. Techdow USA Company Information
 Table 76. Techdow USA Description and Business Overview
 Table 77. Techdow USA Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Techdow USA Lab-synthesized Heparin Product
 Table 79. Techdow USA Recent Developments/Updates
 Table 80. Bruan Company Information
 Table 81. Bruan Description and Business Overview
 Table 82. Bruan Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Bruan Lab-synthesized Heparin Product
 Table 84. Bruan Recent Developments/Updates
 Table 85. Amphastar Company Information
 Table 86. Amphastar Description and Business Overview
 Table 87. Amphastar Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Amphastar Lab-synthesized Heparin Product
 Table 89. Amphastar Recent Developments/Updates
 Table 90. Leo Pharma Company Information
 Table 91. Leo Pharma Description and Business Overview
 Table 92. Leo Pharma Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Leo Pharma Lab-synthesized Heparin Product
 Table 94. Leo Pharma Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Sanofi Lab-synthesized Heparin Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Pfizer Lab-synthesized Heparin Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Shenzhen Hepalink Company Information
 Table 106. Shenzhen Hepalink Description and Business Overview
 Table 107. Shenzhen Hepalink Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Shenzhen Hepalink Lab-synthesized Heparin Product
 Table 109. Shenzhen Hepalink Recent Developments/Updates
 Table 110. Changzhou Qianhong Biopharma Company Information
 Table 111. Changzhou Qianhong Biopharma Description and Business Overview
 Table 112. Changzhou Qianhong Biopharma Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. Changzhou Qianhong Biopharma Lab-synthesized Heparin Product
 Table 114. Changzhou Qianhong Biopharma Recent Developments/Updates
 Table 115. Yantai Dongcheng Biochemicals Co., Ltd Company Information
 Table 116. Yantai Dongcheng Biochemicals Co., Ltd Description and Business Overview
 Table 117. Yantai Dongcheng Biochemicals Co., Ltd Lab-synthesized Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 118. Yantai Dongcheng Biochemicals Co., Ltd Lab-synthesized Heparin Product
 Table 119. Yantai Dongcheng Biochemicals Co., Ltd Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Lab-synthesized Heparin Distributors List
 Table 123. Lab-synthesized Heparin Customers List
 Table 124. Lab-synthesized Heparin Market Trends
 Table 125. Lab-synthesized Heparin Market Drivers
 Table 126. Lab-synthesized Heparin Market Challenges
 Table 127. Lab-synthesized Heparin Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lab-synthesized Heparin
 Figure 2. Global Lab-synthesized Heparin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Lab-synthesized Heparin Market Share by Type: 2023 & 2030
 Figure 4. Low Molecular Weight Heparin Product Picture
 Figure 5. Unfractionated Heparin Product Picture
 Figure 6. Global Lab-synthesized Heparin Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Lab-synthesized Heparin Market Share by Application: 2023 & 2030
 Figure 8. Venous Thromboembolism
 Figure 9. Atrial Fibrillation/Flutter
 Figure 10. Coronary Artery Disease
 Figure 11. Others
 Figure 12. Global Lab-synthesized Heparin Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Lab-synthesized Heparin Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Lab-synthesized Heparin Sales (2019-2030) & (K Dose)
 Figure 15. Global Lab-synthesized Heparin Average Price (US$/Dose) & (2019-2030)
 Figure 16. Lab-synthesized Heparin Report Years Considered
 Figure 17. Lab-synthesized Heparin Sales Share by Manufacturers in 2023
 Figure 18. Global Lab-synthesized Heparin Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Lab-synthesized Heparin Players: Market Share by Revenue in Lab-synthesized Heparin in 2023
 Figure 20. Lab-synthesized Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Lab-synthesized Heparin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Lab-synthesized Heparin Sales Market Share by Country (2019-2030)
 Figure 23. North America Lab-synthesized Heparin Revenue Market Share by Country (2019-2030)
 Figure 24. United States Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Lab-synthesized Heparin Sales Market Share by Country (2019-2030)
 Figure 27. Europe Lab-synthesized Heparin Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Lab-synthesized Heparin Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Lab-synthesized Heparin Revenue Market Share by Region (2019-2030)
 Figure 35. China Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Lab-synthesized Heparin Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Lab-synthesized Heparin Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Lab-synthesized Heparin Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Lab-synthesized Heparin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Lab-synthesized Heparin by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Lab-synthesized Heparin by Type (2019-2030)
 Figure 54. Global Lab-synthesized Heparin Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Lab-synthesized Heparin by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Lab-synthesized Heparin by Application (2019-2030)
 Figure 57. Global Lab-synthesized Heparin Price (US$/Dose) by Application (2019-2030)
 Figure 58. Lab-synthesized Heparin Value Chain
 Figure 59. Lab-synthesized Heparin Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Enoxaparin API Market Research Report 2025
Global Low Molecular Weight Heparin Market Research Report 2025
Global Crude Heparin Market Research Report 2024
Global Heparin Market Insights Forecast to 2030
Low Molecular Weight Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Heparin APIs Market Research Report 2024
Medical Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Sodium Active Pharmaceutical Ingredient Market Research Report 2024
Heparin Heparin Sodium and Heparin Calcium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High Purity Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global LMWH Products Market Insights Forecast to 2030
Global Low Molecular Weight Heparin Injection Market Research Report 2024
Global Heparin Anticoagulant Market Insights Forecast to 2028
Global Low Molecular Weight Heparin Sodium Market Insights Forecast to 2030
Bovine Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Coatings Market Research Report 2024
Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide and Heparin Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions